Industry Focus

The downturn in oil has forced companies to become even more efficient - and that means they require a lower oil price to make profits.

We compare Biogen's and Celgene's current valuations and consider what might be in store for Gilead Sciences now that its new hepatitis C drug is approved.

We talk value investing in tech to follow up our P/E episode on growth investing. Analyst John Rotonti explains some key metrics he looks at and discusses a few companies he really likes in the tech space.

Volkswagen’s price tag to settle its emissions cheating scandal are now over $15 billion, but is it possible that the worst is behind the German auto maker?

Digesting how the U.K. decision to exit the EU could impact healthcare stocks here and abroad.

Is Sin City losing its edge? Special guest Seth McNew gives us a firsthand account of the evolving economy and landscape in Las Vegas as companies look to opportunities outside the smoky casino floor.

Last week’s vote in the United Kingdom to separate from the European Union is the most important thing to happen on the global stage since the end of World War II, rivaling only China’s moves in the 1970s and 1980s to participate actively in the global economy. In this episode of Industry Focus: Financials, The Motley Fool’s John Maxfield and Gaby Lapera put the vote in historical perspective and explain why it has hit stock prices so hard. Then, Dan Caplinger and Gaby follow-up with investing strategies for the economic dip.

We wrap up interns ask week with a question Peter Lynch would love and a discussion of how to "invest in what you know."

Land rig counts that drill for oil & gas have risen 3 weeks in a row, is this the first sign of a turnaround in the sector?

Insurers can make or break drug developers, politicians can derail profits, and tax inversions are dead in the water -- should investors avoid healthcare stocks?

The theme for this week of Industry Focus brings Motley Fool’s summer interns into the studio to learn more about different industries and companies. Minashsha Lamisa wants to know: “What are the potential effects of the recent Orlando tragedy on the gun industry?”

It’s interns week on the Motley Fool’s Industry Focus: Financials edition podcast, a special week when this summer’s most Foolish interns have the chance to pepper host Gaby Lapera and analyst Jay Jenkins with all the financial industry related questions they’ve been thinking but never had the chance to ask.  

We run through Microsoft’s $26 billion purchase of LinkedIn, explain the details of the deal and whether or not it makes sense.

Explaining diabetes, its various treatment options, and what the future may have in store for this disease.

Major U.S. automakers trade at historically low valuations despite huge sales success and spectacular profits. How can this be? The Motley Fool’s John Rosevear and Sean O’Reilly dive in.

Coinciding nicely with National Bourbon Day, we look at the latest developments in the alcohol industry from a spin-off at Constellation Brands to the incredible growth of new “beer” categories and a controversial offering from SodaStream.

There’s more to a fund than just its name. Here’s how to do deep due diligence into the mutual funds in your retirement account. For video highlights of our Fool Fest Digital Pass go to http://digitalpass.fool.com/focus

The video game industry is booming thanks to strong consumer demand, the rise of Esports, and the franchise extensions into other forms of media. Analyst David Kretzman joins us to talk about some trends to watch and his favorite company in the space. 

Elon Musk’s pet project SpaceX is still a private company, but would you invest in it if the situation was otherwise?

What cancer drug companies came out ahead at this weekend's ASCO conference and a closer look at Biogen's recent disappointment.